Black Diamond Therapeutics(BDTX)
$1.52-0.09 (-5.59%)
BDTX
Black Diamond Therapeutics earnings date
$1.52
At close:-0.09 (-5.59%)
Want to see BDTX full AI Analyst Report?
Black Diamond Therapeutics (BDTX) Q2 2021 Earnings Report
1,665 Followers
BDTX Q2 2021 EPS Results
- Actual EPS
- -$0.95
- Consensus EPS
- -$0.87
- Beat/Miss
- Missed by -$0.08
- One Year Ago EPS
- -$0.41
BDTX Q2 2021 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/12/2021
- Time
- Before Open
- Conference Call
- Thursday, August 12, 2021
BDTX Upcoming Earnings
Black Diamond Therapeutics's next earnings date is estimated for March 24, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
BDTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 24, 2027 | 2026 (Q4) | -0.19- | -0.27 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.09-0.17 | -0.15 | -13.33% (-0.02) | |
| Aug 05, 2026 | 2026 (Q2) | -0.20-0.17 | -0.19 | 10.53% (+0.02) | |
| May 07, 2026 | 2026 (Q1) | -0.18-0.16 | 0.98 | -116.33% (-1.14) | |
| Mar 16, 2026 | 2025 (Q4) | -0.18-0.27 | -0.28 | 3.57% (+0.01) | |
| Nov 06, 2025 | 2025 (Q3) | -0.23-0.15 | -0.28 | 46.43% (+0.13) | |
| Aug 07, 2025 | 2025 (Q2) | -0.25-0.19 | -0.36 | 47.22% (+0.17) | |
| May 12, 2025 | 2025 (Q1) | 0.020.98 | -0.35 | 380.00% (+1.33) | |
| Mar 06, 2025 | 2024 (Q4) | -0.32-0.28 | -0.34 | 17.65% (+0.06) | |
| Nov 05, 2024 | 2024 (Q3) | -0.37-0.28 | -0.45 | 37.78% (+0.17) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
